Tianjin Atom High-Tech Isotope Medicine

Tianjin Atom High-Tech Isotope Medicine is a specialized pharmaceutical company focused on the production and distribution of radiopharmaceuticals and medical isotopes. As a key subsidiary of Atom High-Tech Co., Ltd. (HTA) and part of the China Isotope & Radiation Corporation (CIRC) group, the company operates advanced manufacturing facilities in Tianjin. Its product portfolio includes essential diagnostic agents such as Fluorodeoxyglucose [18F] for PET imaging and therapeutic isotopes like Iodine-131 for thyroid cancer treatment. The company plays a critical role in the regional supply chain for nuclear medicine, ensuring the timely delivery of short-lived radioactive products to hospitals and clinics. Tianjin Atom High-Tech maintains rigorous GMP standards to support the growing demand for precision diagnostics and targeted radiotherapy in China.